{"name": "SynGen",
 "permalink": "syngen",
 "crunchbase_url": "http://www.crunchbase.com/company/syngen",
 "homepage_url": "http://syngeninc.com/",
 "blog_url": "http://syngeninc.com/News.htm",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "hardware",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@syngeninc.com",
 "phone_number": "916.706.0923",
 "description": "",
 "created_at": "Thu Apr 19 05:01:19 UTC 2012",
 "updated_at": "Tue Apr 09 05:42:54 UTC 2013",
 "overview": "\u003Cp\u003ESynGen Inc. enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue.  Our products provide an important enabling platform for use in diagnostic, research, and clinical processes. Our inventions are based upon interdisciplinary fields that apply principles of engineering and life sciences to develop solutions required for regenerative medicine.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       84],
      "assets/images/resized/0018/4957/184957v1-max-150x150.png"],
     [[233,
       131],
      "assets/images/resized/0018/4957/184957v1-max-250x250.png"],
     [[233,
       131],
      "assets/images/resized/0018/4957/184957v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Philip",
      "last_name": "H. Coelho",
      "permalink": "philip-h-coelho",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.bizjournals.com/prnewswire/press_releases/2012/04/18/SF89627",
    "source_description": "SynGen Inc. Receives $5 million Equity Investment from Bay City Capital, LLC",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Bay City Capital",
         "permalink": "bay-city-capital",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0004/8963/48963v1-max-150x150.png"],
             [[219,
               36],
              "assets/images/resized/0004/8963/48963v1-max-250x250.png"],
             [[219,
               36],
              "assets/images/resized/0004/8963/48963v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1919 21st Street",
    "address2": "Suite 203",
    "zip_code": "95811",
    "city": "Sacramento",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}